Fosamax Plus D Approval History
- FDA approved: Yes (First approved April 7th, 2005)
- Brand name: Fosamax Plus D
- Generic name: alendronate and cholecalciferol
- Dosage form: Tablets
- Company: Merck & Co., Inc.
- Treatment for: Osteoporosis
Fosamax Plus D is a single once-weekly tablet containing the bisphosphonate drug alendronate, and seven days’ worth of vitamin D, an essential nutrient required for calcium absorption. Fosamax Plus D is used to reduce the risk of hip and spinal fractures in postmenopausal women with osteoporosis, and to increase bone mass in men with osteoporosis.
Development History and FDA Approval Process for Fosamax Plus D
|Apr 7, 2005||Fosamax Plus D Merck & Co., Inc. - Treatment for Osteoporosis|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.